SPGI vs XFOR · P/E 27, rev $15.34B vs rev $4.8M
S&P Global Inc (SPGI) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.
SPGI currently screens at market cap $127.50B and trailing P/E 27.2. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the SPGI and XFOR stock pages for the full models.
Not investment advice.